iShares Us Equity Enhanced Active Ucits ETF USD Acc (USEE) 뉴스

Does the guy run this out of his garage?

I’ll give you the Tigers and raise you the Lions!!!
We’ll see how the former Lion likes a snowball Philly fan base.

Huge gap at $15. Space stocks out of favor right now. Spacex failure doesn’t help.
No Mars contract. Likely financing announcement in the next few months.
50-day MA at $22.50 and 200 day MA at $18.
Support line at around $20.
I think this stock will do well long term but

The good thing is the bottoms are far apart

Extracted from TDD post:
While objective response rate (ORR) was not the primary endpoint, the data does focus on survival as a key metric. The trial did not report significant tumor shrinkage or traditional ORR (complete or partial responses), which may lead some to conclude a "0% ORR" in co

It's going to be a Very Happy 2025! “On behalf of the entire AABB team, we are excited and highly anticipate all the corporate events that will be achieved as the new year progresses. We would like to thank our shareholders and everyone following our Company for their continued support of our vision

RIVN 1-year chart: It’s a big juicy double bottom that’s getting ready for a breakout.

TIkTokBan In Effect -TikTok is down

https://investorshub.advfn.com/uimage/uploads/2025/1/19/svqfpWhatsApp_Image_2025-01-18_at_20.55.42_d9f6033c.jpg

(Nasdaq: ILLR)

That's Because their is NO reason it is a $5.00 + plus stock. Doesn't have the Revenue, Sales, Orders or Cash Flow. Putting all their reserves into Bit Coin It must be run by Geniuses .... NOT Everyone knows it's going down ......

Theory extracting from DD post below is the answer to your question. In short, you don’t understand or comprehend the response or you don’t care to understand the response. You’re looking like a fool.

Extracted from TDD post:
While objective response rate (ORR) was not the pr

TRILLER is NOW the Top #3 Downloaded App

https://investorshub.advfn.com/uimage/uploads/2025/1/19/ohr[kWhatsApp_Image_2025-01-18_at_23.34.11_dddcd0c6.jpg


(Nasdaq:ILLR)

At some point over the coming months, it will be

prudent to short tech in some form imo.

NEEDS AN UPDATE;
Picks AH OF INTEREST IN CANCELLED DEAL $MIKP & $SAKL cancelled recently 03-20-2023 /
SHORTING
DEAL CANCELLED
SAKL BUYS 45% INTEREST IN $MIKP
11-12-2022 SOMETHING IS GOING ON WIT
$MIKP & $SAKL
$SAKL BUYING INTEREST OF 45% OF $MIK

fyi, the RITE CEO sent out letters and updates to shareholders a few months ago, but you know what the cherry on top was?

he HAND SIGNED the letter, that is class, that is professional and unheard of, especially from any CEO let alone a CEO from a PINK OTC stock

i added

Are you aware this is 2025, not 2008. Just so you know there is no current crisis.

Ya think??????????????

NOBODY is going to lend Henry $12.5 billion.

Henries track record speaks for itself. You can go all the way back 30 years and see that Henry has been trying the same cons since then. That said...I'll buy a few mill as soon as this hits .0001 again. Still plenty of stupid people believ

I assume from your comment that your area(s) of expertise/experience is in family care?
Does it expand beyond that?
Scientific or Corporate biotech?

Unsure what imprimatur you wish for your input.

How's your Italian?
https://www.pharmastar.it/pharmastartv//business/amarin-introduce-in-italia-un-nuovo-farmaco-contro-il-rischio-cardiovascolare-residuo-13781

Agree. On a side note is GRRR on your ai radar. Baisicly do same thing as Veri and involved in more. Have a law enforcement platform and involved in smart cities in international markets and just now getting into US market. See my comments on GRRR board

Mufasco,

I agree with you that they are in the copy and modification mode, but keep in mind they can do it at a fraction of the cost. U.S and Euro research has become unsustainable considering the monies that are spent. This is why research Bio's have been a group to avoid.

Let's ROCK!!

https://www.youtube.com/watch?v=_DRNljTgiyg

GOOD MORNING

suit,

Thanks for asking 😶

Your posts, the ASM recording, and the trial results are there for anyone to read/listen and judge for themselves.

Thanks again for reminding us about the ASM and about the past DCVax Direct clinical study at MD Anderso